Clinical Trials Directory

Trials / Completed

CompletedNCT04859933

AV Node Isolation in Atrial Fibrillation vs. Modulation by "Pace and Ablate" Strategy

Status
Completed
Phase
Study type
Observational
Enrollment
60 (actual)
Sponsor
Heart and Diabetes Center North-Rhine Westfalia · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

AV-node ablation (AVNA) is a common therapy option for rate control strategy of permanent atrial fibrillation with numerous side effects. The investigators hypothesised that an isolation of the AV node is concomitant with less occurrence of new bundle brunch blocks, more frequent preservation and higher rate of escape rhythm compared to AVNA. This retrospective study includes 20 patients being treated with AV-node isolation (AVNI) and 40 historical AVNA-controls. Among others these two methods were compared regarding escape rhythm, delta QRS, procedure time, ablation points, fluoroscopy time and total dose area product (DAP).

Conditions

Interventions

TypeNameDescription
PROCEDUREAV-node isolationAbaltion performed in the right atrium isolating the AV-node from the atrium
PROCEDUREAV-node ablationRight sided ablation of the AV-node

Timeline

Start date
2020-10-01
Primary completion
2022-02-28
Completion
2022-02-28
First posted
2021-04-26
Last updated
2022-08-09

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT04859933. Inclusion in this directory is not an endorsement.